| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.099 | 0.0005 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.097 | 0.001 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |